Dr. Gary Walter Unzeitig, MD

Dr. Unzeitig practices at Doctors Hospital of Laredo in Laredo, Texas, part of Universal Health Services.

Dr. Unzeitig's NPI, 1528129921, was assigned on December 12, 2006. Dr. Unzeitig graduated from Feinberg School of Medicine in 1978. Dr. Unzeitig's Texas license number on file is G4065.

Dr. Unzeitig's primary practice is Doctors Hospital of Laredo, at 10700 McPherson Road, Laredo, TX 78041 in Webb County. The practice phone is (956) 523-2000.

Dr. Unzeitig's primary practice is Doctors Hospital of Laredo in Laredo, Texas, part of Universal Health Services. Dr. Unzeitig is also affiliated with Laredo Medical Center. Dr. Unzeitig's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Unzeitig practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Unzeitig's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Unzeitig is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Unzeitig's licenses on file in 2 states: Texas and California.

Dmand AI lists breast reconstruction and mastectomy among the conditions Dr. Unzeitig treats.

CMS data shows 231 Medicare services from Dr. Unzeitig across 5 procedure codes in 2024, for 139 Medicare patients. Medicare paid $27,003 for them. Every service was in an office.

CMS counts 139 Medicare patients who saw Dr. Unzeitig in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Unzeitig's median patient age at 67, with 99% women.

In 2024, Dr. Unzeitig wrote 507 Medicare Part D claims for 160 patients. 100% of them were for generic drugs. CMS names the drug for 494 of them, across 4 drugs with 11 or more claims each, at $9,729 in total drug cost. In 2023, CMS named 488 claims across 4 drugs.

CMS counts 37 procedures of mastectomy by Dr. Unzeitig, more than 90% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Unzeitig, published from 2012 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Neoadjuvant Therapy and Anastrozole. Dr. Unzeitig has published most often in Ann Surg Oncol. Dr. Unzeitig's most frequent co-authors are Kelly K. Hunt, MD, Matthew J. Ellis, MD, PhD and Ann Marilyn Leitch, MD.

Dmand AI links Dr. Unzeitig to 16 clinical trials, 11 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 12 general payments to Dr. Unzeitig from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 50% of the total. Allergan Inc. paid the most, $1,005.

Dmand AI lists 6 awards for Dr. Unzeitig, most recently Humanitarian award in 2020.

Dr. Unzeitig graduated from Feinberg School of Medicine in 1978. Dr. Unzeitig is a member of ACS, ASBS, ASCO and Society of Surgical Oncology.

Dr. Unzeitig is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.